Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Specter Spares Supplements, Hammers DEA Over Illegal Steroid Products

This article was originally published in The Tan Sheet

Executive Summary

A Senate Judiciary subcommittee hearing on "hidden steroids" in bodybuilding products sold as supplements took the Drug Enforcement Administration to task for a delay on restricting access to anabolic steroids

You may also be interested in...



'Big Shoes To Fill' As Hatch Retirement Leaves Supplement Market Legacy

Sen. Orrin Hatch won’t seek re-election and will leave 24 years after Congress passed the Dietary Supplement Health and Education Act as a framework for FDA's regulation of vitamin, mineral and supplement product manufacturing and marketing. Hatch is in his seventh term and is the longest-serving Senate member.

Fabricant Will Helm FDA Dietary Supplement Office

Daniel Fabricant, who championed the dietary supplement industry for the past five years as a Natural Products Association executive, now will oversee supplement industry regulation as an FDA official.

Fabricant Will Helm FDA Dietary Supplement Office

Daniel Fabricant, who championed the dietary supplement industry for the past five years as a Natural Products Association executive, now will oversee supplement industry regulation as an FDA official.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103397

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel